This site uses cookies

Some of these cookies are essential, while others help us to improve your experience by providing insights into how the site is being used.

For more detailed information please check our Cookie notice.

Necessary cookies

Necessary cookies enable core functionality. This website cannot function properly without these cookies.

Cookies that measure website use

If you provide permission, we will use Google Analytics to measure how you use the website so we can improve it based on our understanding of user needs. Google Analytics sets cookies that store anonymised information about how you got to the site, the pages you visit, how long you spend on each page and what you click on while you're visiting the site.

 

Variable

UK Data Service variable record for:

Millennium Cohort Study: First Survey, 2001-2003

Variable Details

Variableamhpwmab
LabelS1 MAIN Type of health problem C1 MC2
Question text What ^was this problem? (1st child) Response 2
Responses
1 Chest infections 0
2 Ear infections 644
3 Feeding problems 194
4 Sleeping problems 45
5 Wheezing or asthma 446
6 Skin problems 1081
7 Sight or eye problems 531
8 Failure to gain weight or to grow 72
9 Persistent or severe vomiting 512
10 Persistent or severe diarrhoea 585
11 Fits or convulsions 35
51 Other/High temperature/acute viral infection unspecified 278
52 Other/Chicken pox 145
53 Other/Measles or whooping cough 23
54 Other/Urinary tract infection 40
55 Other/Infection of nose or throat, croup, flu or severe coug 289
56 Other/Colds 366
57 Other/Thrush 121
58 Other/Other severe infection 59
59 Other/Other mild infection 163
60 Other/Breathing problem 43
61 Other/Eczema 14
62 Other/Other allergy, except wheezing, asthma or eczema 53
63 Other/Colic 83
64 Other/Constipation or bleeding from bowel 138
65 Other/Jaundice 30
66 Other/Hernia 47
67 Other/Reaction(s) to immunisation(s) 27
68 Other/Reflux or other vomiting 33
70 Other/Congenital heart disease, definite 20
71 Other/Congenital heart disease, not yet definite 37
72 Other/Congenital dislocation of hip, definite 6
73 Other/Congenital dislocation of hip, not yet definite 53
74 Other/Clubfoot (Talipes equinovarus), definite 4
75 Other/Talipes, not yet definite 6
76 Other/Specified skeletal abnormalities (bone, skull, spine, 30
77 Other/Urogenital abnormalities 25
78 Other/Gastrointestinal abnormalities 5
79 Other/Harelip/cleft palate 2
80 Other/Skin abnormalities 16
81 Other/Chromosomal or genetic abnormalities 4
82 Other/Brain, central nervous, spinal cord or special sense a 5
83 Other/Other congenital abnormalities major 5
84 Other/Other congenital abnormalities minor 35
85 Other answer (not codeable 1-11, 51-68, 70-84) 279
86 Irrelevant response 3
95 Other health problems 0
-9 Refusal 0
-8 Don't Know 0
-1 Not applicable 11920
DisclaimerPlease note that these frequencies are not weighted.
LocationMillennium Cohort Study: First Survey, 2001-2003
Interviewer Instructions^was this problem = ‘was this problem’ if only one problem [ADMO=1]. ‘were these problems’ if more than one problem [ADMO>1].
UniverseThe sample population for MCS was drawn from all live births in the United Kingdom over 12 months (from 1 September 2000 in England and Wales and for 59 weeks from 22 November 2000 in Scotland and Northern Ireland).;National
SamplingMulti-stage stratified random sample;See documentation for details.
Study TypeLongitudinal/panel/cohort<br><br>Four waves have been conducted to date: MCS1 (age 9 months), MCS2 (age 3 years), MCS3 (age 5 years) and MCS4 (age 7 years).<br><br>The population of eligible live births was selected from a random sample of electoral wards, disproportionately stratified to ensure adequate representation of all four UK countries, deprived areas and those with high concentrations of black and Asian families. See documentation for further details.
UKRI logo

Funded by UKRI through the ESRC with contributions from our partners.

© 2025 UK Data Service
We are supported by the University of Essex, University of Manchester, Jisc, UCL and University of Edinburgh. We are funded by UKRI through the Economic and Social Research Council.